Staffing and Scheduling for Subcutaneous

EP: 1.The Shifting to Subcutaneous Oncology: Recent FDA Approvals

EP: 2.Subcutaneous Value: Efficiency and Access

EP: 3.Workflow Wins: Scheduling and Pharmacy Impact

EP: 4.IV vs Subcutaneous: Clinical Considerations

EP: 5.Reimbursement Realities: Billing for Subcutaneous

EP: 6.Implementing Subcutaneous Without Disruption

EP: 7.Operational Shifts: IV to Subcutaneous

Now Viewing

EP: 8.Staffing and Scheduling for Subcutaneous

Integrating a mix of IV and SubQ therapies into oncology infusion centers requires a flexible and integrated operational model. One effective strategy is cross-utilization of nursing staff, allowing infusion nurses to pivot between IV treatments and SubQ injections as needed. This helps maintain efficiency during cancellations or scheduling gaps. Regular data analysis is also essential to identify peak days, patient volumes, and throughput issues, enabling proactive adjustments in staffing and chair availability. SubQ-specific shot chairs or injection areas can be helpful but must be adaptable to accommodate patient flow and optimize the use of available resources.

A pilot approach to implementation can ease the transition and reduce resistance from staff. Trialing SubQ administration in-clinic, immediately after a physician visit, is one example that can reduce unnecessary movement to the infusion area. These trials give the care team the chance to assess feasibility without committing long-term. Equally important is patient education and experience. Patients who understand the treatment, feel minimal discomfort, and appreciate the time savings are more likely to adhere to care. When patients report positive experiences—such as treatments that better fit their schedule or reduce time spent in the clinic—it fosters long-term engagement with the treatment plan.

However, the shift to SubQ therapy also changes the dynamic for nursing staff. Nurses accustomed to longer infusions may feel disconnected from patients during quick SubQ interactions. It’s important to reframe these moments as opportunities for meaningful one-on-one engagement, rather than seeing them as lost time. Adding privacy features and dedicated injection spaces can improve both patient comfort and nurse workflow. Ultimately, successful integration of SubQ therapies depends on leadership that anticipates challenges, provides clear guidance, and supports a culture of adaptability and ongoing education for the entire clinical team.